Andrographis paniculata extract (HMPL-004) for active ulcerative colitis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/23044768
Conclusion of this study
Patients with mildly to moderately active ulcerative colitis treated with A. paniculata extract (HMPL-004) at a dose of 1,800 mg daily were more likely to achieve clinical response than those receiving placebo.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study